### Bundle Overview

<p> Nomenclature (name, manufacturer) Information on the nomenclature of the drug substance should be provided. For example:
<ul>
<li>GSRS preferred name</li>

<li>Recommended International Nonproprietary Name (INN)</li>

<li>Compendial name if relevant</li>

<li>Chemical name(s)</li>

<li>Company or laboratory code</li>

<li>Other non-proprietary name(s), e.g., national name</li>

<li>Chemical Abstracts Service (CAS) registry number</li>

<li>IUPAC Name</li>

<li>ISBT 128</li>
</ul>
</p>
<p>
For a drug product containing more than one drug substance, the information requested for part “S” should be provided in its entirety for each drug substance
</p><p>
Structure (name, manufacturer) NCE: The structural formula, including relative and absolute stereochemistry, the molecular formula, and the relative molecular mass should be provided.
</p><p>
 Biotech: The schematic amino acid sequence indicating glycosylation sites or other post[1]translational modifications and relative molecular mass should be provided, as appropriate.
 </p>

### eCTD Folder 3.2.S.1.0

<div>{%include SubstanceGeneral.svg%}</div>

### Example 3.2.S.1.0 Bundle

